Paying users zone. Data is covered by .
Get to Abbott Laboratories for $19.99, or
get to entire website for at least 3 months from $49.99.
Enterprise Value to FCFF (EV/FCFF)
Free Cash Flow to The Firm (FCFF)
Abbott Laboratories, FCFF calculation
USD $ in millions
|FCFF||Free cash flow to the firm is the cash flow available to the Abbott Laboratories’s suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.||Abbott Laboratories’s FCFF increased from 2015 to 2016 and from 2016 to 2017.|
Interest Paid, Net of Tax
Abbott Laboratories, interest paid, net of tax calculation
USD $ in millions
|12 months ended||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014||Dec 31, 2013|
|Effective Income Tax Rate (EITR)|
|Interest Paid, Net of Tax|
|Interest paid, before tax|
|Less: Interest paid, tax2|
|Interest paid, net of tax|
2 Interest paid, tax = Interest paid × EITR
= × =
Enterprise Value to FCFF Ratio, Current
Abbott Laboratories, current EV/FCFF calculation, comparison to benchmarks
|Selected Financial Data (USD $ in millions)|
|Enterprise value (EV)|
|Free cash flow to the firm (FCFF)|
|Bristol-Myers Squibb Co.|
|Eli Lilly & Co.|
|Gilead Sciences Inc.|
|Johnson & Johnson|
|Merck & Co. Inc.|
|Regeneron Pharmaceuticals Inc.|
|Pharmaceuticals & Biotechnology|
Based on: 10-K (filing date: 2018-02-16).
If company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.
Enterprise Value to FCFF Ratio, Historical
Abbott Laboratories, historical EV/FCFF calculation, comparison to benchmarks
3 EV/FCFF = EV ÷ FCFF
= ÷ =
|EV/FCFF||Enterprise value to free cash flow to the firm is whole company valuation indicator.||Abbott Laboratories’s EV/FCFF ratio increased from 2015 to 2016 but then declined significantly from 2016 to 2017.|